Amylin Pharmaceuticals (AMLN)

Amylin Pharmaceuticals is engaged in the discovery and development of potential drug candidates for the treatment of metabolic disorders. They are developing SYMLIN for the treatment of people with diabetes who use insulin. Other drugs are currently in very early stages of development.

Address
9373 Towne Centre Drive
San Diego, CA 92121
(858) 552-2200
http://www.amylin.com/

Top Executives
Joseph Cook, Chairman
Ginger Graham, CEO
Mark Foletta, CFO
Daniel Bradbury, COO
Julia Brown, Executive VP

Exchange: Nasdaq
Size: Mid-Cap
SIC Code: 2834
Competitors: PolyMedica, Generex Biotechnology, Insmed, Alteon

InvestorGuide Research Links
Stock: Amylin Pharmaceuticals
Sector: Healthcare, Technology
Industry: Pharmaceutical preparations


Special Offers
Buy AMLN for just $4
Give this profile a rating from 1 to 5 (5 being the best)...
1    2    3    4    5    
Buy Amylin Pharmaceuticals for just $4
www.sharebuilder.com
Trading Currencies Can Be Easy As 1, 2, 3 - Try a Free Practice Account Today.
www.ac-markets.com

See Your Message Here

Browse by Letter: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z